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Aims The aim of the present study was to extend our understanding of international trends in stroke and major sequelae in
Europe and countries peripheral to Europe by assessing: (1) current mortality rates, (2) the most recent 15-year
prevalence trends, and (3) the relationship between systolic blood pressure in community surveys and national
stroke mortality.
Methods
and results
Data were obtained from the World Health Organization (WHO www.who.int/whosis/database/mort/table.cfm),
and represent national vital statistics as reported by 39 countries (European and Central Asian countries) using a
standard format and population-based cardiovascular surveys. Total numbers of deaths by stroke (International
Classification of Diseases 430–438, 444) and the age, sex-adjusted incidence rates were obtained and grouped
according to three standard demographic categories: A, B, and C (WHO). A Bayesian linear mixed effect model
was fitted to the annual mortality rates. Higher rates of stroke mortality were observed for B and C group countries
as compared with those countries belonging to Group A (e.g. Bulgaria 273.9 and 281.1; Israel 37.7 and 45.4 per 100 000
men and women, respectively). Even though the mortality rates within the country groupings were relatively similar,
countries with marked deviation from the average were observed, mainly in Groups B and C. Stroke mortality decreased
sharply in Group A during the period of study; conversely it had increased substantially in Group B and to a lesser extent
in Group C. For both sexes markedly higher rates were noted moving from west to east, with some exceptions.
Conclusion We have entered a period of rapidly increasing international inequality in stroke risk, where countries with low adult
mortality in the latter 20th century extended their downward trend and countries with moderate as well as high
mortality have on average seen unprecedented increases in death rates from stroke.
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Introduction
Stroke has long been recognized as a major problem for public
health. One, stroke ranks third (after MI and cancer) as a cause
of death around the world.1 Two, stroke is responsible for 3%
of adult disability2 and analyses based on vital record and data
imputation have established that the 15 million incident strokes
occurring each year around the world result in 5 million deaths
and an additional 5 million patients living with permanent sequelae
and dependency.1 Three, because of the progressive ageing of the
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population, and the increased prevalence of major risk factors for
stroke (hypertension, diabetes, obesity, etc.), stroke is expected to
increase in the coming decades, leading to the prediction being that
the rate of stroke may double by the year 2020.2
The above situation justifies current emphasis on the need to
control risk factors that are responsible for the majority of
strokes, above all hypertension.3 –7 It also justifies the growing
attention being given to the prevalence of stroke and its temporal
trends in different regions of the world, in order to incorporate
new knowledge and have a better global insight into factors,
(genetic, environmental, and health care system), that play a
major role in determining stroke occurrence and outcomes. This
has led to interesting although unexplained observations. For
example, North American countries appear to have a markedly
lower stroke mortality than Europe,8– 10 which is in turn character-
ized by a highly heterogeneous mortality rate between different
countries and regions.8,9 Also, although the burden of stroke has
declined monotonically in many countries since 1900,11 an increase
has been reported in the second part of the 1st century for
countries such as Portugal and from 1990 the stroke burden has
shown an unexpected and startling new rise in the former Soviet
Union and Eastern European countries.12,13
The aim of the present study was to extend our understanding
of these international trends in stroke by assessing its mortality
rate as well as recent 15-year trends using detailed data from
Europe and countries peripheral to Europe, as available from the
World Health Organization (WHO). Another goal of the study
was to examine the extent to which these data can be used as a
marker of the burden of uncontrolled hypertension in populations,
given that an elevated blood pressure accounts for about
two-thirds of strokes worldwide.14
Materials and methods
Study population
This analysis is based on information provided in the electronic data-
bases of the WHO (www.who.int/whosis/database/mort/table.cfm).
All data represent the vital statistics as reported from individual
country ministries using a standard format. Stroke mortality (Inter-
national Classification of Diseases 430–438, 444) rates stratified by
age and sex are presented for countries in the region with a population
of 500 000 or more. Rates were not computed for countries with a
very low level of vital registration, ,60%. Coverage was calculated
for each country by dividing the number of stroke deaths reported
for any given year by the total number of deaths estimated by
WHO for the population of that country during that year. The
WHO national population death estimate was based on the UN
Population Division, 2006 revision.
It should be noted that the WHO estimates may not be completely
accurate. First, for a given country data may not be entirely comparable
due to incomplete vital registration, coverage of only some parts of the
national population, or differences between the vital registration popu-
lation and the de facto population as estimated by UN. Second, some
national vital registration systems may record not only deaths of per-
manent residents but all deaths occurring in the country. Third, in
some other cases deaths of citizens living abroad are included. No
data were available in subjects ,45 years of age. However, the total
number of deaths is this group is known to be negligible. The WHO
estimates of death rates by age and sex were adjusted for incomplete-
ness and used to obtain the total number of deaths per country.
Mortality data
We included data from 35 countries (see Table 1) in Europe and
Central Asia. A subset of countries from both geographical areas
were excluded (Iceland, Luxemburg, Malta, San Marino and Turkey)
due to absence of the required information. The data were obtained
by permission of the WHO Office.
The total numbers of deaths produced by stroke and the age- and
sex-adjusted incidence of fatal stroke were obtained for each
country and grouped according to three demographic categories as
designated by the WHO15,16: Category A, countries with very low
child and adult mortality; Category B, countries with low child and
adult mortality; category C, countries with low child and high adult
(see Table 1).
Statistical analysis
A Bayesian linear mixed effect model17 was fitted to the annual mor-
tality rates with the year as an explanatory variable in the 39 countries
analysed. Fixed effects were used to model the average linear trend for
the three groups of countries. Random effects, for both the intercept
and slope of the trend, have been included in the analysis to model the
deviation of a country within its grouping. Independent standard devi-
ations have been considered for the random effects in each of the
three groups. Non-informative uniform prior distributions have been
used for the coefficients of the fixed effect terms and for the standard
deviations of the random effects. Results are presented as the mean
and the 95% confidence interval. Inference on the Bayesian mixed
effect regression model was made with the software WinBUGS
1.4.3. Data management and graphical representation of the
results (including maps) were made with the R Statistical package
(version 2.8.1).
Results
Stroke mortality, 2002
Across all countries, a total of 1 226 144 stroke deaths were
recorded. There was a large excess mortality for stroke in
women as compared with men (739 000 vs. 487 000, respectively),
a consequence primarily of the female life expectancy advantage.
Because stroke is pre-eminently a disease of the elderly, 60% of
deaths occurred in persons .75 years old and only 4% in subjects
,55. A strong age–sex interaction was thus apparent. Below 65
years of age the stroke mortality rates were significantly higher
among men (male/female ratio ¼ 1.72), whereas this relationship
was reversed over 75 years of age (male/female ratio ¼ 0.42). In
absolute terms the mortality burden was maximal in the countries
from Group C (n ¼ 673,601), followed by Group A (n ¼ 397,473)
and B (n ¼ 155,070). Although stroke mortality in all countries was
concentrated in the oldest age groups, substantial numbers of
deaths were observed among the younger individuals.
Age- and sex-adjusted stroke mortality rates per 100 000 inhabi-
tants are presented in Table 1. Higher mortality rates for women
as compared with men persisted in the majority of the countries,
although this is in part a result of incomplete adjustment for age
among the very elderly when 10 year age strata are used. Higher
rates of stroke mortality were observed in countries in Groups
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B and C compared with those in Group A. Even though the mor-
tality rates within the groupings were relatively homogeneous,
some outliers were observed. For example, in Group A, Greece
and Portugal had rates twice the average. Large deviations from
average values were also observed in Group B (highest rate in
Bulgaria and Romania) and in Group C (highest rates in Latvia
and the Russian Federation).
The higher rates of stroke mortality observed in Group B and C
countries as compared with those in Group A were higher in the
youngest groups. The stroke mortality rate in Group B was four
times more than in Group A in subjects ,65 years while it was
only 1.7 times more in .75 years for men and women. Likewise,
in Group C it was 5 times more than in Group A in the youngest
and 1.8 times in the oldest.
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Table 1 Age-specific and age-adjusted stroke mortality by country, by sex, 2002 (per 100 000 inhabitants)
Country per WHO groupa Men Women
Total 45–54 55–64 65–74 751 Total 45–54 55–64 65–74 751
Group A
Austria 75.8 13 46.1 189.2 1109.2 124.4 13.4 27.4 118 1099.7
Croatia 169.1 58 191.4 644.3 2159.4 206.2 27.1 90.4 414.2 1907.9
Czech Rep 130.5 32.9 107.9 466.8 1988.6 192.1 14 54.2 312.7 2043.7
Finland 70.3 24.6 63.2 211.7 910.4 114.7 17.1 33.2 144.1 1035.6
France 53.1 15.1 34.9 132.7 634.2 69.4 8.7 16.3 67.4 625.3
Germany 70.3 15.3 48.2 184.3 934.9 116.6 10.5 24.9 108.4 991.9
Greece 143.9 23.3 76.3 306.3 1763.2 194.6 14.6 37.4 211.1 2177
Ireland 51 14.5 35 170.9 935.6 71.1 12.1 20.1 109.6 991.9
Israel 37.7 9.4 40.5 180.2 677.8 45.4 6.3 22.6 108.3 693.3
Italy 95.9 14.1 41.1 168.5 1129.2 133.5 9.8 24.3 101.4 1113.7
Netherlands 60.5 14.2 43.8 188.6 892.7 90.6 18.2 31.4 114.9 945.6
Norway 76.5 10 39.1 187.2 994.1 112.5 10.3 22 115.1 1031
Portugal 168.4 39.2 105.6 412.9 2048.1 207.6 18.7 52.8 249.6 2052.1
Slovenia 86.3 30 89.9 354.5 1265.3 114.4 20.4 43.1 162.4 1148
Spain 73.7 16.2 44.8 169.3 880.4 99.9 8.7 21 98.1 934.3
Sweden 91.4 13.3 43.1 186.3 992.1 132.4 11.9 28.2 124 1076.8
Switzerland 48 6.7 19.7 99 658.7 70.2 6.2 13.4 59.7 666.7
United Kingdom 88.3 18.5 49.2 202 1101.4 138 15.7 35.6 146.1 1274.4
Group B
Albania 94.8 31.9 108 533.9 2547.8 97.1 14.5 65.3 420.7 2162.1
Azerbaijan 57 51 220.4 575.1 1293.9 69.9 37.3 168.4 500.8 1397.8
Bulgaria 273.9 98.1 308.1 890.8 2587.1 281.1 44.2 147.4 618.7 2398.3
Kyrgyzstan 118.6 174.4 618.3 1367.5 2348.5 138.4 126.3 411.6 968.9 2729.7
Poland 94 51.4 153.3 427.6 1291.9 119.9 28.6 72 282.5 1285.1
Romania 238.8 107 355.7 981.8 2785.9 267.2 60.5 203 722.5 2704.5
Serbia Montenegro 197.1 69 232.9 738.4 1936.9 237.8 49.2 167.5 644.9 1962.6
Slovakia 84.4 37 125.5 402.4 1344.7 92.5 8.5 40.7 248.8 1120.1
Group C
Belarus 183.2 138 447.1 974.2 1848.4 219.7 67.2 242.5 655.8 1675.1
Estonia 160.5 73.3 249.4 716.1 1940.7 247.1 34.8 105.6 456.6 2145.1
Hungary 172.8 88.4 214.4 651.9 1920 190.8 34.4 94.3 366.4 1662.5
Kazakhstan 121.1 144.4 450.5 1087.8 2192.9 150.4 74.5 281.4 716.1 2387.7
Latvia 225.9 89.8 361 1000.7 2886.6 337 47.9 181.7 638.1 2794.3
Lithuania 120.9 56.1 173.7 499.9 1703.3 179.3 33.6 102.4 351.7 1680.9
Rep Moldova 164.8 124.4 441.1 1094.2 2485.2 197.6 85.2 339 821.9 2324.2
Russian Fed 275.4 159.3 605.4 1619.3 3553.4 396.6 76.9 304 1022.1 3687.4
Ukraine 190.3 117.9 369.6 873.4 2081.8 253.2 59.8 205.9 598.4 2046.6
Data not available for Belgium, Bosnia, Denmark and Georgi.
aGroup according to ref. 15 (see text).
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Trends in stroke mortality, 1990–2006
Linear trends in stroke mortality were fitted for each group of
countries, separately for males and females, using the mixed
effect model. The corresponding average regression lines for every
group of countries are shown in Figure 1. In Group A stroke mor-
tality decreased sharply from 1990 to 2006 whereas in Group B
and to a lesser extent in Group C an increase was observed. For
each of the three country groupings the rate of mortality in the
year 1998 (the mid-year of the study period), the annual variation
during the whole period, and the standard deviations of the
random effects around the mean of its group, is presented in
Table 2. Data refer to individual countries. In both sexes the
highest mortality rates were seen for Group C followed by
sequentially by Groups B and A. The annual increment was
higher for Group B than for Group C, although the difference
was not statistically significant. The standard deviation of the
annual variation among countries was lower in Group A than in
Group B or C, indicating greater homogeneity.
Disaggregated country-specific data are summarized in Figure 2 in
which the geographical distribution of the mortality rate for stroke is
shown for the mid-year of the study period, i.e. 1998. For both sexes
the stroke mortality rate shows marked between-country variations
with a clear tendency to increase sharply moving from west to east.
There were nevertheless also clear exceptions. For example, Portu-
gal is at the upper range of mortality risk while Kyrgyzstan appears to
be relatively low. For men, the country with the highest rate of stroke
mortality is Bulgaria (267.6) whereas, the lowest mortality rate was
observed in Israel (45.1). For women, the country with the highest
rate is the Russian Federation (351.0), while the lowest rate was
again Israel (51.6).
Figure 3 presents the geographic distribution of the annual rate
of change in stroke mortality during the period 1990–2006 in each
country, again based on mixed effects model. In general Western
Europe has experienced a consistent decrease in stroke mortality.
Figure 1 Mean trend for mortality rates for each of the country Groups A, B and C (see text).
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Table 2 Means and 95% confident intervals in the
mixed effect models for group of countries
Group of
countries
Males Females
Average rate for every group (per 100 000 people), year 1998
Group A 93.94 [75.44, 112.30] 129.95 [107.50, 153.40]
Group B 136.87 [86.84, 186.49] 155.35 [108.00, 201.89]
Group C 169.55 [138.20, 199.69] 235.78 [185.61, 283.46]
Annual variation of the mortality rate for the whole period
Group A 22.03 [22.62, 21.51] 22.67 [23.40, 21.86]
Group B 2.08 [20.02, 4.25] 2.51 [20.12, 4.96]
Group C 1.71 [21.08, 4.23] 0.72 [22.76, 4.11]
Standard deviation of the mortality rate (year 1998) for countries in
every group
Group A 41.53 [30.17, 59.56] 50.85 [36.46, 73.55]
Group B 76.00 [50.72, 98.13] 77.22 [53.82, 98.35]
Group C 46.11 [27.30, 81.78] 72.99 [49.33, 153.40]
Variability (SD) of annual variation of the rate for countries in every
group
Group A 1.26 [0.85, 1.82] 1.65 [1.14, 2.38]
Group B 3.06 [1.66, 5.65] 3.87 [2.20, 6.91]
Group C 3.84 [2.19, 6.90] 4.67 [2.59, 8.51]
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However, in Eastern Europe a single homogeneous pattern is not
apparent, and countries with virtually no temporal changes can be
seen vis-a`-vis countries in which a considerable increase in mor-
tality is recorded. For men the country with the highest annual
increase in mortality rate is Serbia and Montenegro (annual
increase of 6.9 deaths per 100 000 men), while the lowest one is
Portugal (24.9). For women, the country with the highest
annual increase is again Serbia and Montenegro (9.1) while the
greatest decrease is seen in Austria (25.4).
Discussion
A downward trajectory in stroke mortality has been the historical
norm and in some countries this pattern has been documented
from as early as 1900.11 In this report, we extend the description
of stroke mortality trends in Europe, Russia, Central Asia and a
group of smaller countries in the European sphere to the last 15
years. The striking conclusion that emerges is that stroke mortality
has entered a period of rapidly increasing inequality between
countries. Countries which had attained low mortality rates
reached in the latter part of the 20th century experienced
further declines, while countries with moderate as well as high
stroke mortality (Groups B and C in this report) at the start of
the period being examined had a further unprecedented increase
in this cause of death.13,18
The data reported in the present study from the WHO permit a
detailed analysis of the impact of stroke mortality in Europe and
the differences among countries since 1990. As noted, stroke con-
tinues to exact a disproportionate toll among women. This sex
imbalance reflects an age-crossover effect, whereby rates are
higher among men at a younger age, but the longevity advantage
of women allows more of them to reach the age of greatest
stroke risk. This pattern is also consistent with the age-related
cross-over in blood pressure (BP) levels among men vs. women
and the selective survival of healthier men to old age. Secondly,
age-adjusted stroke mortality varies four-fold among European
countries, and most strikingly the current trends are also highly
divergent. While a constant decrease was observed in most
countries, some other countries show persistently high rates and
another subset experienced a steep upward trajectory which con-
tinued into the last year analysed. Third, in general, countries with
the highest economic standard of living showed the lowest inci-
dence and the greatest decline in stroke mortality. However,
some exceptions should be noted. For example, Portugal and
Greece showed high rates of stroke mortality in the baseline
year, but despite this a continuous decline was observed. In con-
trast, and with some exceptions, lower income countries were
found to not only have higher stroke mortality in 1990 but a per-
sistent increase over time. Also to be noticed is that in countries
such as Portugal and Greece the high rate of stroke mortality
coexists with a prevalence of coronary heart disease, which is
known to be among the lowest in Europe.19 This can be explained
for differences in the prevalence and control of some risk factors,
mainly hypertension.
Figure 2 Geographical distribution of the mortality rate for stroke for the mid-year of the study period (1990–2006) in men (upper panel)
and women (lower panel).
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The present data raise a series of important questions. Why are
there such large differences among the European countries? How
can this variation be reduced so that more populations share the
benefits of cardiovascular prevention? The reason for the large
differences is an intriguing question that deserves careful reflec-
tion due to the huge impact on health care.20,21 Considering the
close relationship of stroke and BP independent of age and sex,
simple variation in BP itself would appear to be a plausible
explanation. A significant relationship in univariate and in a multi-
variate analyses between systolic BP and the stroke mortality
among countries was reported for Johnston et al.,14 although
the importance of systolic BP values was surpassed by the variable
income. Low income is an important marker of risk since it
reflects not only a combination of socioeconomic variables,
such as income itself and unemployment, but also derived psycho-
social and dietary factors, prevalence of classic cardiovascular risk
factors and access to medical care. Furthermore, estimates of
country income are more reliable than country-level systolic BP
values, thus also favouring a more robust relationship for
income than for systolic BP.22
Prior ecological analyses—both among countries and among
regions within countries—have shown a reasonably strong corre-
lation between BP or hypertension prevalence and stroke mor-
tality,8,9,23 and the consistency of these relationships has
suggested that stroke rates could serve as an outcome measure
reflecting the success of high BP control efforts. It has also been
recognized in the last few years that in populations with similar
standards of living, such as North America and Western Europe,
mean BPs among normotensive persons can vary substantially,
presumably reflects the level of exposure to causal risk factors.24
Taken together, this evidence suggests that at least part of
the long-term decline in stroke has resulted from falling average
BPs.
Wolf-Maier et al. estimated the prevalence of hypertension in
Europe compared with the USA and Canada8 and treatment strat-
egies on Germany, Sweden, England, Spain, Italy, Canada, and the
USA using national surveys conducted in the 1990s.9 The preva-
lence of hypertension was 60% higher in Europe compared with
the USA and Canada. Likewise, Redon et al.25 in a cross-sectional
study of population .60 years old in Spanish primary care centres,
stroke mortality rates were significantly related to indexes of
worse blood pressure handling, low control rates and high left-
ventricular hypertrophy, independent of age, sex, obesity, diabetes,
and urban setting. Moreover, Boshuizen et al.,26 analysing 35-year
follow-up data on mortality of stroke among subjects aged 65
years or more from nine cohorts of the Seven Countries Study,
observed that past and recent SBP was related to stroke mortality.
Asplund et al.27 in the MOnica Risk, Genetics, Archiving and Mono-
graph (MORGAM) Project concluded that the impact of the indi-
vidual risk factors differed somewhat between countries/regions
with high blood pressure being particularly important in central
Europe (Poland and Lithuania). Recently, Campbell et al.28
Figure 3 Geographical distribution of the annual rate of change in stroke mortality during the study period (1990–2006) in men (upper
panel) and women (lower panel).
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reported a progressive reduction in hospitalization and mortality
for stroke from 1999. This reduction started with the introduction
of the Canadian Hypertension Educational Programme and was in
parallel with an increment in antihypertensive prescriptions. The
gap between improving hypertension control and reducing
stroke mortality, however, remains a matter deserving close study.
Hypertension remains the leading cause of mortality and the
third largest cause of disability worldwide29. Although estimates
vary,30 the consistent message is that in Europe the proportion
of patients with acceptable BP control is low even among those
who are diagnosed and treated in the first place31. Likewise BP
control differs among countries in Europe, although there are
limited data based on studies conducted with the same method-
ology. Recognizing the difficulties in obtaining timely and compar-
able population surveys, alternative methods to assess the BP
status across populations could be an important quality indicator
for health systems. Assessing the incidence and trends of
hypertension-induced clinical conditions could prove useful in
this regard. Among the options for a surveillance measure,
stroke incidence presents an attractive option.32
If we assume that stroke mortality can serve as a proxy for
average BP in a population, the data presented here clearly demon-
strate the necessity to adopt actions to increase the diagnosis,
treatment and hypertension control in the countries where the
burden of hypertension sequelae is still growing. Policies to
increase the rate of BP control offer the best approach, while
primary prevention strategies must also be implemented.
The study has to be interpreted within the context of its limit-
ations and strengths. With an ecological approach, we explored
possible relationships between health statistics and population
characteristics, stroke mortality rates, and prevalence of cardiovas-
cular risk factors. Although inferences from associations observed
in an ecological study may not necessarily pertain to the individuals
within the group, especially when outcomes from long-term
exposures were studied, they help to develop hypotheses for
further evaluation with analytical studies and they have a distinct
advantage because of their statistical power to detect small risks.
Estimates may be subject to ecological bias33 but neither theoreti-
cal nor empirical analysis has offered consistent guidelines for the
interpretation of ecological analysis. In addition, changes in the
codification of diseases over time can be contributed to some of
the sharp jumps in mortality rates observed but the general
trends would not result from the code changes.
Summary
Stroke mortality accounts for a large proportion of mortality in
Europe and the trend is to increase in absolute numbers, due to
an ageing population and for the increment observed in many
countries. This underlying challenge which needs to be confronted
is shifting the distribution curve of the blood pressure to the left in
the population while increasing the rate of diagnosis, treatment and
control of hypertension. Future studies should search for more
detailed information concerning the role of stroke mortality as a
proxy of the hypertension status in populations.
Conflict of interest: none declared.
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